GMP Manufacturing Support
Development, manufacturing, testing, and quality services supporting successful clinical programs
Advancing Manufacturing Readiness
Transitioning a drug candidate into GMP manufacturing requires expertise across development, scale-up, quality systems, analytical testing, and regulatory documentation. MRIGlobal provides integrated support that helps organizations reduce development risk, strengthen manufacturing readiness, and accelerate progress toward clinical trials.
Supporting GMP Manufacturing Success
Process Development & Optimization
Develop and refine manufacturing processes to improve robustness, reproducibility, and scalability.
Scale-Up Support
Translate laboratory processes into manufacturing-ready operations suitable for clinical production.
Technology Transfer
Facilitate transfer of manufacturing knowledge, methods, and processes between development and production environments.
Analytical & Quality Support
Perform method development, testing, and quality activities needed to support GMP production.
Stability Studies
Generate data that supports storage conditions, shelf-life determinations, and regulatory submissions.
Regulatory Documentation
Provide technical and quality documentation that supports clinical manufacturing and regulatory filings.
Latest from the blog
-
MRIGlobal’s SCALE Center is a major part of the $34 Million Tech Hubs Award that the EDA intends to provide to the KC BioHub Consortium
Kansas City’s newest chapter in a long tradition of world-changing science: bringing life-saving medicines closer to the patients who need them.
Biologics Pharmaceutical -
Safeguarding a Clinical Trial Amid Regulatory and Logistical Constraints
Expertise enabled client to proceed without delay
Clinical Trial Materials Management Foreign-Trade Zone Warehouse & Distribution -
Trouble with Tariffs?
On Thursday, Sept. 25, President Trump announced 100% tariffs on some imported brand-name drugs starting October 1, unless manufacturers build U.S. plants to boost domestic production. As this new tariff policy is enacted, it may have an adverse impact on pharmaceutical companies by increasing the cost of importing raw materials, drug substances and drug products, […]
Clinical Trial Materials Management Foreign-Trade Zone Warehouse & Distribution
